Is Saffron Social Anxiety Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Saffron Social Anxiety Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - An increasing body of evidence suggests that these features may be modulated by sex-related differences. [Scenna Marta Sofia (2026); evidence level 3] - In addition, it can also be associated with other medical conditions including epilepsy, congenital cardiac defects, gastrointestinal (GI), immunological, endocrine/metabolic and sleep disorders, as well as psychiatric comorbidities like ADHD and anxiety. [Scenna Marta Sofia (2026); evidence level 3] - The role of environmental factors in ASD became evident with the observation that advanced paternal and maternal age is associated with an increased likelihood of having a child with ASD (). [Scenna Marta Sofia (2026); evidence level 3] - Lord et al., 2018 Faja and Dawson, 2017 Dellapiazza et al., 2022 Napolitano et al., 2022 Figure 1 Autism spectrum disorder (ASD) is a lifelong neurodevelopmental disorder characterized by deficits in social communication and interaction, as well as restricted and repetitive patterns of behavior, interests, and activities, often accompanied by atypical sensory-motor responses (). [Scenna Marta Sofia (2026); evidence level 3] - 73% of participants agreed that they found the app easy to use overall and that an app is a good format for offering anxiety support to autistic people. [Oakley B (2025); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.